000			01992nam a22002417a 4500
001			D0001J000168
003			DOH
005			20210317092935.0
008			210317b ||||| |||| 00| 0 eng d
245	0	0	_aTherapeutic value of levocabastine eye drops in the treatment of allergic conjunctivitis, a comparative study versus antazoline-tetrahydrozoline eye drops / _cJacinto U. Dy-Liacco [and four others]
520	3		_aThis double-blind comparative study was done to assess and compare the efficacy and safety of levocabastine eye drops in Filipino patients having allergic conjunctivitis versus those of antazoline-tetrahydrozoline eye drops. A total of 54 children and adult were randomized to receive either levocabastine eye drops 0.5 mg/mL administered twice daily or antazoline (0.5 mg/mL)- tetrahydrozoline (0.4 mg/mL) administered four times a day with a treatment duration of two weeks. The patients were classified, depending on the severity of the signs and symptoms of their allergic conjunctivitis, into three categories namely: mild, moderate, and severe. Global evaluation of treatment was rated as excellent, good, moderate or unsatisfactory. Overall therapeutic response was found to be comparable for the two treatment groups. There were also no significant differences between the adverse reactions arising from both drugs. In conclusion, levocabastine is as safe and effective as antazoline-tetrahydrozoline for the treatment of allergic conjunctivitis with its additional advantages of having a faster onset of action and lesser frequency of administration.
580			_aActa Medica Philippina,1997 33 ( 3 ) pages 157-164
650		2	_aLubricant Eye Drops
650		2	_aOphthalmic Solutions
653			_aLevocabastine
653			_aAntazoline-tetrahydrozoline
700	1		_aDy-Liacco, Jacinto U.
700	1		_aSiong, Ruben Lim B.
700	1		_aEltanal, Ma. Antonette
700	1		_aKabamalan, Ma. Gracia
700	1		_aValencia, Cynthia I.
942			_cJA
999			_c3569 _d3569